Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers
Results
Phase 3
This trial looked at how well ceritinib worked for people whose non small cell lung cancer had changes to a protein called ALK. This is called ALK positive non small cell lung cancer (NSCLC).
It was for people having their first treatment for advanced lung cancer.
Recruitment start: 19 May 2013
Recruitment end: 11 May 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Raffaele Califano
NIHR Clinical Research Network: Cancer
Novartis
Last reviewed: 19 Apr 2018
CRUK internal database number: 11220
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
